comparemela.com
Home
Live Updates
Department Of Oncologic Sciences - Breaking News
Pages:
2
3
4
5
6
7
8
Latest Breaking News On - Department of oncologic sciences - Page 1 : comparemela.com
Dr Eroglu on Addressing Unmet Needs in Mutant Melanoma
Zeynep Eroglu, MD, discusses a phase 1/2 trial that evaluated ceritinib alone and in combination with trametinib in patients with mutant melanoma.
Zeynep eroglu
Moffitt cancer center
Department of oncologic sciences
Department of cutaneous oncology
Cutaneous oncology
Oncologic sciences
South florida morsani college
Moffitt cancer center
Melanoma amp skin cancer
Onclive tv
Dr Eroglu on Ceritinib With or Without Trametinib in Pretreated Advanced Melanoma
Zeynep Eroglu, MD, discusses the efficacy and safety of ceritinib as monotherapy and in combination with trametinib in pretreated advanced melanoma.
Zeynep eroglu
Department of cutaneous oncology
Moffitt cancer center
Department of oncologic sciences
Cutaneous oncology
Oncologic sciences
South florida morsani college
Pretreated advanced melanoma
Toxicities Hinder Potential Efficacy of Ceritinib/Trametinib in Pretreated Advanced Melanoma
Zeynep Eroglu, MD, discusses how findings from a phase 1/2 study of ceritinib and trametinib could help inform future research in melanoma.
Zeynep eroglu
Keiran smalley
Moffitt cancer center
Department of oncologic sciences
Cutaneous oncology
Oncologic sciences
South florida morsani college
Ceritinib and trametinib
Dr Eroglu on the Safety Profile of Ceritinib Plus Trametinib in Advanced Melanoma
Zeynep Eroglu, MD, discusses the safety profile of ceritinib plus trametinib in pretreated metastatic melanoma.
Zeynep eroglu
University of south florida
Moffitt cancer center
Department of oncologic sciences
Department of cutaneous oncology
Morsani college of medicine
Cutaneous oncology
Oncologic sciences
South florida
Morsani college
Skin cancer
Onclive tv
Ceritinib plus trametinib
Dr Eroglu on Future Steps for Assessing Ceritinib Plus Trametinib in Metastatic Melanoma
Zeynep Eroglu, MD, discusses future steps for assessing ceritinib in combination with trametinib in patients with metastatic melanoma.
Zeynep eroglu
Department of oncologic sciences
Department of cutaneous oncology
Moffitt cancer center
Cutaneous oncology
Oncologic sciences
South florida morsani college
vimarsana © 2020. All Rights Reserved.